Tech Company Financing Transactions
Circle Pharma Funding Round
On 9/13/2016, Circle Pharma raised $3.8 million in investment from private investors.
Transaction Overview
Company Name
Announced On
9/13/2016
Transaction Type
Debt
Venture Equity
Venture Equity
Amount
$3,808,348
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. 4 investors participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
681 Gateway Blvd. LGL 3rd Floor
San Francisco, CA 94080
USA
San Francisco, CA 94080
USA
Phone
Website
Email Address
Overview
We design and develop bioavailable macrocyclic peptide therapeutics against important clinical targets. We do this by applying a computational structure-based design approach that combines physics (conformational modeling), chemistry (innovative molecular components) and biology (protein target structure and function).
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
David Earp
Chief Scientific Officer
Rajinder Singh
Co-Founder
Matthew Jacobson
Co-Founder
Scott Lokey
Vice President
James Aggen
VP - Operations
Amy Cowgill
VP - R & D
Pablo Garcia
VP - R & D
Constantine Kreatsoulas
Browse more venture capital transactions:
Prev: 9/13/2016: Datorama venture capital transaction
Next: 9/14/2016: Brazen venture capital transaction
Share this article
Where The Data Comes From
We record every notable VC transaction. VC investment data records reported here are derived from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs